Public Health England (PHE) -
This report, co-authored by PHE's National Cancer Registration and Analysis Service and Cancer Research UK, is the first major report using systemic anticancer treatment data. This data gives trust-level insights about real-world chemotherapy treatment of patients in the NHS in England which was previously only available from clinical trials. The report shows that age, general wellbeing and other factors can affect 30-day mortality following chemotherapy for breast and lung cancer. This report is a companion to an open-access study paper published in The Lancet Oncology.